CymitQuimica logo

DRI-c21045

CAS:

Ref. 3D-BJD76581

5mg
Discontinued
10mg
Discontinued
25mg
Discontinued
50mg
Discontinued
100mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

DRI-c21045
Biosynth

Product Information

Name:DRI-c21045
Brand:Biosynth
Description:DRI-c21045 is an analog of a medicinal compound that has been shown to inhibit the activity of a specific protein kinase involved in cell cycle regulation and tumor growth. This inhibitor has been demonstrated to induce apoptosis in cancer cells, making it a promising candidate for anticancer therapy. DRI-c21045 has been tested in both Chinese and human cancer cell lines and has shown potent activity against various types of tumors. Additionally, this compound has been detected in urine samples from patients with cancer, suggesting that it may have potential as a diagnostic marker for certain types of cancer. Overall, DRI-c21045 shows great promise as a potential anticancer agent with significant therapeutic potential.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:580.6 g/mol
Formula:C32H24N2O7S
Purity:Min. 95%

Inquiry about discontinued product: DRI-c21045

◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.